CIM
TMO icon

CCLA Investment Management’s Thermo Fisher Scientific TMO Stock Holding History

CCLA Investment Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$155M Sell
267,601
-33,437
-11% -$18.9M 2.49% 10
2025
Q3 		$146M Sell
301,038
-16,843
-5% -$7.84M 2.33% 14
2025
Q2 		$129K Buy
317,881
+50,695
+19% +$21.2M 0.1% 25
2025
Q1 		$133M Buy
267,186
+8,615
+3% +$4.67M 2.35% 15
2024
Q4 		$134M Buy
258,571
+8,985
+4% +$4.94M 2.13% 19
2024
Q3 		$137M Hold
249,586
– – 2.12% 11
2024
Q2 		$137M Buy
249,586
+2,493
+1% +$1.43M 2.12% 11
2024
Q1 		$143M Buy
247,093
+2,024
+0.8% +$1.14M 2.2% 10
2023
Q4 		$131M Buy
245,069
+63,401
+35% +$30.7M 2.14% 13
2023
Q3 		$92M Buy
181,668
+21,594
+13% +$11.5M 1.72% 25
2023
Q2 		$83.4M Buy
160,074
+17,399
+12% +$9.39M 1.49% 32
2023
Q1 		$82.1M Sell
142,675
-582
-0.4% -$328K 1.61% 28
2022
Q4 		$78.9M Sell
143,257
-615
-0.4% -$326K 1.78% 24
2022
Q3 		$73.2M Buy
+143,872
New +$80.5M 1.77% 24
2022
Q1 		$93.3M Buy
157,721
+8,182
+5% +$4.7M 1.68% 26
2021
Q4 		$99.8M Sell
149,539
-9,503
-6% -$5.93M 1.64% 31
2021
Q3 		$90.9M Buy
159,042
+975
+0.6% +$535K 1.51% 32
2021
Q2 		$79.8K Buy
158,067
+86
+0.1% +$40.6K 0.97% 38
2021
Q1 		$72.2M Sell
157,981
-29,431
-16% -$14M 1.44% 35
2020
Q4 		$87M Sell
187,412
-14,308
-7% -$6.71M 1.96% 22
2020
Q3 		$89M Sell
201,720
-5,704
-3% -$2.36M 2.41% 12
2020
Q2 		$75.1M Buy
+207,424
New +$69.5M 2.35% 13

Other funds holding TMO

JSC
J. Stern & Co London, United Kingdom $1.03B AUM 20.71% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

CCLA Investment Management's TMO Position: Q4 2025 in Review

CCLA Investment Management reduced its Thermo Fisher Scientific (TMO) stake by 11% in Q4 2025, selling an estimated $18.9M and leaving 267,601 shares worth $155M. The position accounts for 2.49% of the portfolio, ranked #10.

CCLA Investment Management first reported a position in TMO in Q2 2020 and has held it in 22 quarters since. 2,699 funds tracked by Wall St. Rank hold TMO as of Q4 2025.

  • CCLA Investment Management held 267,601 shares of Thermo Fisher Scientific worth $155M as of Q4 2025.
  • CCLA Investment Management sold 33,437 Thermo Fisher Scientific shares in Q4 2025, an estimated $18.9M.
  • Thermo Fisher Scientific made up 2.49% of CCLA Investment Management's portfolio in Q4 2025, its #10 holding.
  • CCLA Investment Management first reported a position in Thermo Fisher Scientific in Q2 2020 and has held it in 22 quarters since.
  • 2,699 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2025.

Based on CCLA Investment Management's 13F filing for Q4 2025, filed 22 Jan 2026.